Naiot venture accelerator is dedicated to advancing life science innovation in Israel. We are the host of innovative medical devices, therapeutic and diagnostic. Now, under the scientific leadership of Professor Moussa Youdim and the business leadership of Avi Goldsobel, we are moving forward to creating new pharmaceutical and drug delivery pipeline projects.
Professor Moussa Youdim and his team from the Eve Topf Center of Excellence For Neurodegenerative Diseases Research, who developed Azilect ®, Teva's marketed product for Parkinson's disease have now joined Naiot. Together, with high level scientific expertise and leaders within Israel's investment community who have joined our group, Naiot can offer its portfolio companies and project leaders the best and most pragmatic direction for development, commercialization and funding
Our model consists of:
- Creation of new project companies to be incorporated in Technology Incubator
- Creation of new project companies and fund projects through external investors and matched R&D budget from the Office of the Chief Scientist
- Equity investments in existing companies
- R&D projects within Naiot
Naiot has developed a new and unique funding and finance instrument for start-ups in the biomed area
